Incidence, severity, risk factors and outcomes of Sars-CoV-2 reinfections during the Omicron period
A systematic review and meta-analysis
Dados Bibliográficos
| ID | 19552002 |
|---|---|
| Autores | Durga Kulkarni (0000-0002-7680-1168), Bohee Lee (0000-0002-9671-386X), Nabihah Farhana Ismail, Ahmed Ehsanur Rahman (0000-0001-9216-1079), Julia Spinardi (0000-0002-4324-0317, Pfizer, Vaccines, Emerging Markets, New York, New York, USA), Moe H Kyaw (0000-0002-0258-6645, Pfizer, Vaccines, Emerging Markets, New York, New York, USA), Harish Nair (0000-0002-9432-9100) |
| Ano | 2025 |
| Volume | 15 |
| Data de publicação | 2025-02-07 |
| Peer Reviewed | Sim |
| Open Access | Sim |
| Tipo | ARTICLE |
| Periódico | Journal of Global Health (JOURNAL) |
| Identificadores do periódico | ISSN: 2047-2978 • E-ISSN: 2047-2986 |
| Editora | International Society of Global Health (PUBLISHER • GB) |
| DOI | 10.7189/jogh.15.04032 |
| Idioma | EN |
| Referências citadas | 49 |
The PRISMA 2020 statement
To PCR or not? The impact of shifting policy from PCR to rapid antigen tests to diagnose Covid-19 during the omicron epidemic
An ecological study on reinfection rates using a large dataset of RT-qPCR tests for Sars-CoV-2 in Santiago of Chile
Severity and outcomes of Omicron variant of Sars-CoV-2 compared to Delta variant and severity of Omicron sublineages
Incidence and outcome of Sars-CoV-2 reinfection in the pre-Omicron era
| Velocidade de citação | historical |
|---|---|
| Altamente citado | Não |